Mendelian Randomization and Parkinson’s Disease

Description

Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of monogenic Parkinson’s disease forms. Chapters delve into genomics, transcriptomics, epigenomics, artificial intelligence, and gene-environment interactions. Furthermore, it examines the potential therapeutic applications of these advancements and provides insights into the future of omics research in Parkinson’s disease.

 

Training and Networking Working Group

The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group

Meet the authors

Neuroscientist

Arinola Sanyaolu, PhD

University of Lagos | Lagos, Nigeria

Team leader of a working group

Wael Mohamed, MD, PhD

International Islamic University | Malaysia

Pre-doctoral Intramural Research Training Awardee

Mary B Makarious, BSc

National Institutes of Health | USA

Postdoctoral Associate

Joanne August, PhD

University of Florida | USA

Humboldt Research Fellow

Karl Heilbron, PhD

Charité - Universitätsmedizin Berlin | Berlin, Germany

Postdoctoral researcher

Maria Teresa Periñan Tocino, MSc

Instituto de Biomedicina de Sevilla | Spain

Principal Investigator

Alastair Noyce, MD, PhD

London, UK

Staff Scientist

Sara Bandres-Ciga, PharmD,PhD

National Institutes of Health | USA